The effect of anagliptin on blood glucose and lipid levels in type 2 diabetes mellius
Phase of Trial: Phase IV
Latest Information Update: 15 Jun 2017
Price : $35 *
At a glance
- Drugs Anagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- 13 Jun 2017 Status changed from active, no longer recruiting to completed.
- 18 Jun 2015 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 11 Dec 2013 New trial record